Role of dosage regimen in controlling indirect pharmacodynamic responses

Advanced Drug Delivery Reviews

Volumn 46, Issue 1-3, 2001, Pages 45-57

  Gobburu, Jogarao V S ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Corticosteroids; Diuretics; Drug delivery; Erythropoietin; Growth hormone; Insulin; Pharmacodynamic availability; Prolactin secretion; Simulation; Sustained release; Therapeutic efficiency

Indexed keywords

DRUG;

ALGORITHM; AREA UNDER THE CURVE; ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; DOSE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHARMACOKINETICS; PHARMACOLOGY;

ALGORITHMS; AREA UNDER CURVE; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACOLOGY;

EID: 0035290941     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00132-0     Document Type: Article

References (23)

1. N.L. Dayneka, V. Garg, W.J. Jusko, Comparison of four basic models of indirect pharmacodynamic responses, J. Pharmacokin. Biopharm. 21 (1993) 457-478.
2. R. Nagashima, R.A. O'Reilly, G. Levy, Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin, Clin. Pharmacol. Ther. 10 (1969) 22-35.
3. A.-N. Kong, E.A. Ludwig, R.L. Slaughter, P.M. Distefano, J. Demasi, E. Middleton, W.J. Jusko, Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects, Clin. Pharmacol. Ther. 46 (1989) 616-628.
4. P. Francheteau, J.-L. Steimer, C. Dubray, D. Lavene, Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922, J. Pharmacokin. Bipharm. 19 (1991) 287-309.
5. G. Movin-Osswald, M. Hammarlund-Udenaes, Remoxipride: pharmacokinetics and effect of plasma prolactin, Br. J. Clin. Pharmacol. 28 (1991) 355-360.
6. G. Alvan, L. Helleday, A. Lindholm, E. Sanz, T. Villen, Diuretic effect and diuretic efficiency after intravenous dosage of frusemide, Br. J. Clin. Pharmacol. 29 (1990) 215-219.
7. M. Wakelkamp, G. Alvan, J. Gabrielsson, G. Paintaud, Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration, Clin. Pharmacokin. Ther. 60 (1996) 75-88.
8. J. Murphy, W. Casey, L. Lasagna, The effect of dosage regimen on the diuretic efficacy of chlorothiazide in human subjects, J. Pharmacol. Exp. Ther. 134 (1961) 286-290.
9. S. Kaojarern, B. Day, D.C. Brater, The time course of delivery of furosemide into urine: An independent determinant of overall response, Kidney Int. 22 (1982) 69-74.
10. K.J. Park, W.H. Yoon, W.G. Shin, M.G. Lee, The effect of IV infusion time on the PK and PD of the same total dose of azosemide in rabbits, Biopharm. Drug Disp. 18 (1997) 41-52.
11. G. Castaneda-Hernandez, C. Hoyo-Vadillo, J.E. Herrera, Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration, Int. J. Clin. Pharmacol. Ther. 33 (1995) 56-60.
12. E.V. Mishina, W.J. Jusko, Inhibition of rat splenocyte proliferation with methylprednisolone: In vivo effect of liposomal formulation, Pharm. Res. 11 (1994) 848-854.
13. O.L. Johnson, J.L. Cleland, H.J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A.J.S. Jones, S.D. Putney, A month-long effect from a single injection of microencapsulated human GH, Nature Medicine 2 (1996) 795-799.
14. H. Derendorf, Pharmacodynamic aspects of systemic drug delivery, Drug. Develop. Indust. Pharm. 20 (1994) 485-502.
15. A. Sharma, W.J. Jusko, Characterization of four basic models of indirect pharmacodynamic responses, J. Pharmacokin. Biopharm. 24 (1996) 611-635.
16. W.G. Reiss, R.L. Slaughter, E.A. Ludwig, E. Middleton Jr., W.J. Jusko, Steriod dose sparing: Pharmacodynamic responses to single versus divided doses of methylprednisolone in man, J. Allergy Clin. Immunol. 85 (1990) 1058-1066.
17. A.I. Nichols, W.J. Jusko, Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen, J. Pharmacokin. Biopharm. 18 (1990) 189-208.
18. T.P.J. Dormans, J.M. Joseph, P.G.G. Gerlag, Y. Tan, F.G.M. Russel, P. Smits, Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion, J. Am. Coll. Cardiol. 28 (1996) 376-382.
19. G. Alvan, G. Paintaud, S.-A. Eckernas, A. Grahnen, Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect, Br. J. Clin. Pharmacol. 34 (1992) 47-52.
20. T. Laursen, J.O.L. Jorgensen, G. Jakobsen, B.L. Hansen, J.S. Christiansen, Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients, J. Clin. Endocrin. Metab. 80 (1995) 2410-2418.
21. C. Breymann, C. Bauer, A. Major, R. Zimmermann, K. Gautschi, A. Huch, R. Huch, Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers, Br. J. Haematol. 92 (1996) 295-301.
22. G. Ruotolo, P. Micossi, G. Galimberti, M.C. Librenti, G. Petrella, S. Marcovina, G. Pozza, B.V. Howard, Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes, Metabolism 39 (1990) 598-604.
23. C.D. Saudek, W.C. Duckworth, A. Giobbie-Hurder, W.G. Henderson, R.R. Henry, D.E. Kelley, S.V. Edelman, F.J. Zieve, R.A. Adler, J.W. Anderson, R.J. Anderson, B.P. Hamilton, T.W. Donner, S. Kirkman, N.A. Morgan, Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus, J. Am. Med. Assoc. 276 (1996) 1322-1327.